Arrowhead Pharmaceuticals's total assets for Q1 2026 were $1.60B, an increase of 15.80% from the previous quarter. ARWR total liabilities were $1.04B for the fiscal quarter, a 18.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.